Francesca Barone - 12 Feb 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Scientific Officer
Signature
/s/ Charles Schoch, as Attorney-in-Fact for Francesca Barone
Issuer symbol
CADL
Transactions as of
12 Feb 2025
Net transactions value
$0
Form type
4
Filing time
14 Feb 2025, 16:30:03 UTC
Previous filing
17 Jan 2025
Next filing
20 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +115,000 $0.000000 115,000 12 Feb 2025 Common Stock 115,000 $8.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney. This Power of Attorney was inadvertently omitted from the Form 4 filed on July 15, 2024.